TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36412328

Group type: EXPERIMENTAL
Intervention: 20 ml of 0.25% plain bupivacaine
Number of subjects: 50

Group type: COMPARATOR
Intervention: 20 ml normal saline
Number of subjects: 50
Study: 32071923

Group type: EXPERIMENTAL
Intervention: 12-week exercise program
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 74
Study: 35177432

Group type: EXPERIMENTAL
Intervention: ACTION Respecting Choices (RC) ACP intervention
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 162
Study: 33887400

Group type: EXPERIMENTAL
Intervention: Prolonged Target Temperature Management (TTM) at 33 ± 1 °C for 48 hours
Number of subjects: 79
Study: 32180131

Group type: EXPERIMENTAL
Intervention: Citicoline and vitamin B12 eye drops (OMK2®, Omikron Italia srl, Italy, 3 drops/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo eye drops containing hypromellose 0.3% (3 drops/day)
Number of subjects: 20
Study: 36207894

Group type: EXPERIMENTAL
Intervention: Low-dose vaccine
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Medium-dose vaccine
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: High-dose vaccine
Number of subjects: 422

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Overall (all groups)
Number of subjects: 422
Study: 32994466

Group type: EXPERIMENTAL
Intervention: Belotecan 0.5 mg/m2 for five consecutive days every 3 weeks
Number of subjects: 140

Group type: COMPARATOR
Intervention: Topotecan 1.5 mg/m2 for five consecutive days every 3 weeks
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Belotecan
Number of subjects: 140

Group type: COMPARATOR
Intervention: Topotecan
Number of subjects: 140
Study: 34263581

Group type: EXPERIMENTAL
Intervention: Remimazolam 0.2 mg/kg (R1 group)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Remimazolam 0.3 mg/kg (R2 group)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Remimazolam 0.4 mg/kg (R3 group)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Propofol (P group)
Number of subjects: 189
Study: 33172293

Group type: EXPERIMENTAL
Intervention: Improved nutrition in early life
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 33358691

Group type: EXPERIMENTAL
Intervention: lumacaftor/ivacaftor
Number of subjects: 70

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 70
Study: 32057103

Group type: EXPERIMENTAL
Intervention: Fluorescence cholangiography using 0.05 mg/kg indocyanine green
Number of subjects: 120

Group type: COMPARATOR
Intervention: X-ray cholangiography
Number of subjects: 120
Study: 35730711

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 33478452

Group type: EXPERIMENTAL
Intervention: Programmatic public health intervention (contact registry, training, TB booklet)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Healthcare worker knowledge and perceptions
Number of subjects: 184
Study: 36069654

Group type: EXPERIMENTAL
Intervention: Peer-assisted video-based education programme (VTPA) and counselling 3 days a week for 2 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 50
Study: 32788412

Group type: EXPERIMENTAL
Intervention: Stay Strong, Stay Healthy (SSSH)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Walking (WALK)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 46
Study: 35917866

Group type: EXPERIMENTAL
Intervention: Calcium chloride (5 mmol)
Number of subjects: 391

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 391
Study: 32703270

Group type: EXPERIMENTAL
Intervention: Blue dishware
Number of subjects: 18

Group type: COMPARATOR
Intervention: White dishware
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both dishware conditions
Number of subjects: 18
Study: 35887238

Group type: EXPERIMENTAL
Intervention: Normobaric oxygen (10%, 15%, 30%, 100%)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen (1.4 ATA, 2.5 ATA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control for CD146 and TSP
Number of subjects: 48
Study: 32790002

Group type: EXPERIMENTAL
Intervention: Traditional role scenarios (e.g., health visitor and cot death)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Expanded role scenarios (e.g., firefighter and stopping smoking)
Number of subjects: 369
Study: 34080572

Group type: EXPERIMENTAL
Intervention: Listening to relaxing music and meditating for 45 minutes before sexual intercourse (Group 1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: 30 mg dapoxetine (Group 2)
Number of subjects: 120
Study: 32085792

Group type: EXPERIMENTAL
Intervention: Jakyakgamcho-tang (JGT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: COMPARATOR
Intervention: JGT and Placebo
Number of subjects: 30
Study: 33945227

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 162

Group type: COMPARATOR
Intervention: iGlar
Number of subjects: 162
Study: 33066804

Group type: EXPERIMENTAL
Intervention: Extraforaminal ligaments
Number of subjects: 4

Group type: COMPARATOR
Intervention: Nerve root traction load
Number of subjects: 4
Study: 35908275

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 400 mg, 800 mg, or 1200 mg QD
Number of subjects: 1251

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1251
Study: 34275398

Group type: EXPERIMENTAL
Intervention: Canaliculotomy with curettage and silicone tube intubation (Group B)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Canaliculotomy with curettage without silicone tube intubation (Group A)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Canaliculotomy without intubation (Group A)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Canaliculotomy with intubation (Group B)
Number of subjects: 47
Study: 33210278

Group type: EXPERIMENTAL
Intervention: Intensive four-week structured group relaxation-training program (sophrology's dynamic relaxation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33197294

Group type: EXPERIMENTAL
Intervention: Recombinant zoster vaccine (RZV)
Number of subjects: 29305

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29305
Study: 32744380

Group type: EXPERIMENTAL
Intervention: janagliflozin 25 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: janagliflozin 50 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: dapagliflozin 10 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 36
Study: 32883044

Group type: EXPERIMENTAL
Intervention: School-based multicomponent intervention (7-month after-school program plus curricular physical education)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual curricular lessons
Number of subjects: 64
Study: 36130222

Group type: EXPERIMENTAL
Intervention: Whole almonds (56 g/d)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Ground almonds (56 g/d)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Almonds (whole and ground pooled)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Ground almonds
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control muffin (isocaloric)
Number of subjects: 87
Study: 35911237

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy with Acceptance and Commitment Therapy (CBT-ACT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Care (primary care referral)
Number of subjects: 0
Study: 32209338

Group type: EXPERIMENTAL
Intervention: Durvalumab 10 mg/kg every 2 weeks
Number of subjects: 713
Study: 36078247

Group type: EXPERIMENTAL
Intervention: Parent–Child Interaction Therapy (PCIT)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Services as Usual (SAU)
Number of subjects: 204
Study: 35377157

Group type: EXPERIMENTAL
Intervention: Chocolate Touch DCB
Number of subjects: 313

Group type: COMPARATOR
Intervention: Lutonix DCB
Number of subjects: 313
Study: 32309889

Group type: EXPERIMENTAL
Intervention: Monochrome Superb Microvascular Imaging (mSMI)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Color Superb Microvascular Imaging (cSMI)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Color Doppler Imaging (CDI)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Power Doppler Imaging (PDI)
Number of subjects: 41
Study: 36306368

Group type: EXPERIMENTAL
Intervention: Proxy-CBA
Number of subjects: 73

Group type: COMPARATOR
Intervention: MCQ-CBA
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both CBA formats
Number of subjects: 73
Study: 33199228

Group type: EXPERIMENTAL
Intervention: Osimertinib plus cisplatin/carboplatin plus pemetrexed
Number of subjects: 66

Group type: COMPARATOR
Intervention: Osimertinib monotherapy
Number of subjects: 66
Study: 36050657

Group type: EXPERIMENTAL
Intervention: PlayOn!® playground curriculum implemented in intervention schools
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control schools (no intervention in year one)
Number of subjects: 14
Study: 32995880

Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) targeting the anterior intraparietal sulcus (aIPS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Functional Magnetic Resonance Imaging (fMRI) combined with TMS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 0
Study: 33499521

Group type: EXPERIMENTAL
Intervention: Phototherapy kiosk (PK) treatments for 10 weeks
Number of subjects: 88

Group type: COMPARATOR
Intervention: Vitamin D3 oral supplement (OS) for 10 weeks
Number of subjects: 88
Study: 36315843

Group type: EXPERIMENTAL
Intervention: TURKOVAC
Number of subjects: 222

Group type: COMPARATOR
Intervention: CoronaVac
Number of subjects: 222
Study: 34476464

Group type: EXPERIMENTAL
Intervention: Problem-solving therapy (PST) for depression over 2 months
Number of subjects: 108

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Problem-solving therapy (PST) for depression
Number of subjects: 108
Study: 32338580

Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis (CDT)
Number of subjects: 1915

Group type: COMPARATOR
Intervention: Systemic thrombolysis (ST)
Number of subjects: 1915
Study: 36098893

Group type: EXPERIMENTAL
Intervention: Families First parenting program (10-week intervention)
Number of subjects: 736

Group type: EXPERIMENTAL
Intervention: Families First parenting program
Number of subjects: 736

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 736
Study: 32924207

Group type: EXPERIMENTAL
Intervention: cBAI (computer-delivered brief alcohol intervention)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Standard care (brief education and advice)
Number of subjects: 138
Study: 35201931

Group type: EXPERIMENTAL
Intervention: Lumbar intrathecal fentanyl (FENT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 36462609

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 59
Study: 33626500

Group type: EXPERIMENTAL
Intervention: Exercise programs that include deadlifts
Number of subjects: 3

Group type: COMPARATOR
Intervention: Low load motor control exercises
Number of subjects: 3
Study: 32740235

Group type: EXPERIMENTAL
Intervention: mFOLFIRINOX
Number of subjects: 103

Group type: COMPARATOR
Intervention: gemcitabine/nab‐paclitaxel
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Postoperative therapy
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Postoperative complications
Number of subjects: 103
Study: 33199491

Group type: EXPERIMENTAL
Intervention: Genomically directed therapy
Number of subjects: 177

Group type: COMPARATOR
Intervention: Physician's choice
Number of subjects: 177
Study: 32363656

Group type: EXPERIMENTAL
Intervention: General cognitive training (GCT)
Number of subjects: 4184

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4184
Study: 34220720

Group type: EXPERIMENTAL
Intervention: Whey Protein (15 g)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (water, 100 ml)
Number of subjects: 24
Study: 35980261

Group type: EXPERIMENTAL
Intervention: Scopolamine hydrobromide (4-6 µg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Glycopyrronium bromide (4 µg/kg)
Number of subjects: 40
Study: 33410336

Group type: EXPERIMENTAL
Intervention: Brief Cognitive Behavioral Therapy for Insomnia (bCBTi) - four weekly sessions
Number of subjects: 19
Study: 32401718

Group type: EXPERIMENTAL
Intervention: Platelet rich plasma intradermal injections
Number of subjects: 30
Study: 35003725

Group type: EXPERIMENTAL
Intervention: One-time combination cefazolin 2 g and metronidazole 500 mg preoperatively
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Tinzaparin 4500 units SC daily for at least 7 days after discharge
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 250
Study: 33157325

Group type: EXPERIMENTAL
Intervention: Open flap debridement (OFD) + adjunctive photodynamic therapy (PDT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open flap debridement (OFD)
Number of subjects: 0
Study: 35618650

Group type: EXPERIMENTAL
Intervention: Sedated esophagogastroduodenoscopy followed by unsedated colonoscopy (Group A)
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Sedated esophagogastroduodenoscopy followed by sedated colonoscopy (Group B)
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Sedated esophagogastroduodenoscopy followed by sedated insertion colonoscopy (Group C)
Number of subjects: 3200
Study: 34140010

Group type: EXPERIMENTAL
Intervention: BCG scar present
Number of subjects: 1320

Group type: COMPARATOR
Intervention: BCG scar absent
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Overall birthweight
Number of subjects: 1320

Group type: EXPERIMENTAL
Intervention: Maternal factors
Number of subjects: 1320
Study: 32030616

Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 75
Study: 35352627

Group type: EXPERIMENTAL
Intervention: Laser treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hormone treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 0
Study: 35470799

Group type: EXPERIMENTAL
Intervention: 1-month DAPT after PF-DCS
Number of subjects: 2020

Group type: COMPARATOR
Intervention: 6-12-month DAPT after BP-DES
Number of subjects: 2020
Study: 32350016

Group type: EXPERIMENTAL
Intervention: Tailored diabetes education and behavioural weight management programme (DEW)
Number of subjects: 576

Group type: COMPARATOR
Intervention: Diabetes education programme (DE)
Number of subjects: 576
Study: 35158461

Group type: EXPERIMENTAL
Intervention: Inebilizumab
Number of subjects: 17
Study: 33862589

Group type: EXPERIMENTAL
Intervention: Flexyn2a vaccine (10 µg)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 33758921

Group type: EXPERIMENTAL
Intervention: Modified dairy fat meals (25g SFAs, 20g MUFAs for breakfast; 15g SFAs, 12g MUFAs for lunch)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control dairy fat meals (32g SFAs, 12g MUFAs for breakfast; 19g SFAs, 7g MUFAs for lunch)
Number of subjects: 52
Study: 35257698

Group type: EXPERIMENTAL
Intervention: iCanQuit
Number of subjects: 550

Group type: COMPARATOR
Intervention: QuitGuide
Number of subjects: 550
Study: 33208642

Group type: EXPERIMENTAL
Intervention: Accelerometer-based portable navigation system (navigation group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional intramedullary femoral guide and extramedullary tibial guide (conventional group)
Number of subjects: 100
Study: 35175316

Group type: EXPERIMENTAL
Intervention: Capecitabine maintenance therapy (1000 mg/m2 orally twice daily on days 1‐14 every 3 weeks) plus best supportive care (BSC)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Best supportive care (BSC) alone
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Capecitabine maintenance therapy
Number of subjects: 104
Study: 34536718

Group type: EXPERIMENTAL
Intervention: PGDT group
Number of subjects: 482

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 482
Study: 34591500

Group type: EXPERIMENTAL
Intervention: Intensive Short‐Term Dynamic Psychotherapy (ISTDP)
Number of subjects: 27
Study: 32283187

Group type: EXPERIMENTAL
Intervention: 16-week lifestyle behavior intervention promoting stress management, healthy eating, and physical activity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 0
Study: 35467744

Group type: EXPERIMENTAL
Intervention: NHFOV
Number of subjects: 1440

Group type: COMPARATOR
Intervention: NCPAP
Number of subjects: 1440

Group type: COMPARATOR
Intervention: NIPPV
Number of subjects: 1440
Study: 32985999

Group type: EXPERIMENTAL
Intervention: Voice-Button Reporting (VBR)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Voice-Only Reporting (VOR)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: System Usability Scale (SUS)
Number of subjects: 57
Study: 35763213

Group type: EXPERIMENTAL
Intervention: Daily oral 600 IU vitamin D supplementation
Number of subjects: 40

Group type: COMPARATOR
Intervention: No supplementation (Control)
Number of subjects: 40
Study: 33632921

Group type: EXPERIMENTAL
Intervention: Community outreach methods and community liaison support
Number of subjects: 166
Study: 35759611

Group type: EXPERIMENTAL
Intervention: Online discussion with no fact-check available
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Online discussion with fact-check from traditional media
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Online discussion with fact-check from a fact-check organization
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control group with no online discussion
Number of subjects: 320
Study: 33156757

Group type: EXPERIMENTAL
Intervention: Empirical TB treatment
Number of subjects: 850

Group type: COMPARATOR
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 850
Study: 35941979

Group type: EXPERIMENTAL
Intervention: Core balance training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 33685241

Group type: EXPERIMENTAL
Intervention: Baseline period included
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No baseline period
Number of subjects: 0
Study: 32098946

Group type: EXPERIMENTAL
Intervention: 20 Hz rTMS
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 56
Study: 34182842

Group type: EXPERIMENTAL
Intervention: Computerized cognitive remediation therapy (CCRT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study: 33905129

Group type: EXPERIMENTAL
Intervention: 12 SQ-Bet
Number of subjects: 929

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 929
Study: 32393159

Group type: EXPERIMENTAL
Intervention: Neighborhood-level residential mobility (percentage of residents living in a different house in the past year and percentage of non-owner-occupied housing)
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Individual-level factors (male gender, older age, unemployment, lower education level)
Number of subjects: 418
Study: 35797241

Group type: EXPERIMENTAL
Intervention: Liraglutide (GLP-1 analogue) for 6 months
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Liraglutide (GLP-1 analogue)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 30
Study: 32277781

Group type: EXPERIMENTAL
Intervention: Genetically elevated LDL cholesterol
Number of subjects: 1286

Group type: EXPERIMENTAL
Intervention: Genetically elevated total cholesterol
Number of subjects: 1286

Group type: EXPERIMENTAL
Intervention: Total cholesterol PRS
Number of subjects: 1286

Group type: EXPERIMENTAL
Intervention: LDL cholesterol PRS
Number of subjects: 1286

Group type: COMPARATOR
Intervention: HDL cholesterol PRS
Number of subjects: 1286

Group type: COMPARATOR
Intervention: Triglycerides PRS
Number of subjects: 1286
Study: 35281554

Group type: EXPERIMENTAL
Intervention: 104 mg subcutaneous injection of Depo‐subQ
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: 150 mg subcutaneous injection of Depo‐Provera
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of 150 mg Depo‐Provera every 6 months
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of Depo‐subQ at 3-month intervals
Number of subjects: 101
Study: 35240330

Group type: EXPERIMENTAL
Intervention: Traditional Dietary Advice (TDA)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Low FODMAP Diet (LFD)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Gluten-Free Diet (GFD)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: All diets (TDA, LFD, GFD)
Number of subjects: 99
Study: 36053934

Group type: EXPERIMENTAL
Intervention: Attention-based cognitive behavioral treatment (nine weekly sessions)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Active-control (not specified)
Number of subjects: 51
Study: 33630880

Group type: EXPERIMENTAL
Intervention: 1-week diet break with increased energy intake (carbohydrate) to predicted weight maintenance requirements
Number of subjects: 26
Study: 33197559

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg daily
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 32406573

Group type: EXPERIMENTAL
Intervention: Lobeglitazone (0.5 mg)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Sitagliptin (100 mg)
Number of subjects: 247
Study: 33390282

Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 1364

Group type: EXPERIMENTAL
Intervention: Statin use in the IAD arm
Number of subjects: 1364
Study: 34823497

Group type: EXPERIMENTAL
Intervention: PDA10 (Epoetin-alpha)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Eprex®
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PDA10
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PDA10 and Eprex®
Number of subjects: 0
Study: 33167893

Group type: EXPERIMENTAL
Intervention: Electric ear acupuncture (EEA)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (spinal anesthesia alone)
Number of subjects: 56
Study: 35690151

Group type: EXPERIMENTAL
Intervention: Monitored Anesthesia Care (MAC)
Number of subjects: 204

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 204